These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21909977)

  • 1. Performing clinical studies involving hernia mesh devices: what every investigator should know about the FDA investigational device exemption (IDE) process.
    Ashar BS; Dang JM; Krause D; Luke MC
    Hernia; 2011 Dec; 15(6):603-5. PubMed ID: 21909977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FDA's role in medical device clinical studies of human subjects.
    Saviola J
    J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidance for the emergency use of unapproved medical devices; availability--FDA. Notice.
    Fed Regist; 1985 Oct; 50(204):42866-7. PubMed ID: 10274027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label use of medical devices in radiology: regulatory standards and recent developments.
    Smith JJ
    J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; investigational device exemptions--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(225):64617-26. PubMed ID: 10338870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical device recalls and the FDA approval process.
    Zuckerman DM; Brown P; Nissen SE
    Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Food and Drug Administration's perspectives on pediatric cardiac assist devices.
    Chen EA; Patel-Raman SM; Berman MR; Zuckerman BD
    ASAIO J; 2008; 54(2):147-9. PubMed ID: 18356646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology assessment of medical devices at the Center for Devices and Radiological Health.
    Kessler L; Richter K
    Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDA medical device approval: things you didn't learn in medical school or residency.
    Buch B
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of research: is it a drug trial or a supplement trial?
    Chen ST
    Fitoterapia; 2011 Jan; 82(1):14-6. PubMed ID: 21073930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US FDA perspective on the regulations of medical-grade polymers: cyanoacrylate polymer medical device tissue adhesives.
    Mattamal GJ
    Expert Rev Med Devices; 2008 Jan; 5(1):41-9. PubMed ID: 18095895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA's perspectives on cardiovascular devices.
    Chen EA; Patel-Raman SM; O'Callaghan K; Hillebrenner MG
    J Cardiovasc Transl Res; 2009 Jun; 2(2):143-6. PubMed ID: 20559979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marketing approval for the lithotripter.
    Nightingale SL; Young FE
    Isr J Med Sci; 1986; 22(7-8):519-23. PubMed ID: 3781809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory initiatives for natural latex allergy: US perspectives.
    Farnham JJ; Tomazic-Jezic VJ; Stratmeyer ME
    Methods; 2002 May; 27(1):87-92. PubMed ID: 12079422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA working to ensure the safety of medical devices used in the pediatric population.
    Flack MN; Gross TP; Reid JS; Mills TT; Francis J
    Pediatr Clin North Am; 2012 Dec; 59(6):1355-66. PubMed ID: 23116531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Center for Devices and Radiological health: an update.
    Donawa M
    Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.